Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

ABSTRACT:

SUBMITTER: Macfarlane S 

PROVIDER: S-EPMC12184016 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature